IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive: Conversely, after IFN is discontinued, a small number of patients remain in cytogenetic or molecular remission for months to years without treatment [12], suggesting possible elimination of CML, or the persistence of residual undetectable LSC, which may be intrinsically constrained, controlled by indirect mechanisms that suppress growth, or both.